EUCTR2004-002560-17-IT进行中（未招募）1 期
A multicenter, double-blind, flexible-dose, 6-month trial comparing the efficacy and safety of asenapina with olanzapine in stable subjects with predominant, persistent negative symptomsof schizophrenia
ORGANON ITALIA0 个研究点目标入组 444 人开始时间: 2005年12月15日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 444
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A multicenter, double- blind, flexible-dose, 6-month extension trial comparing the safety and efficacy of asenapine with olanzapine in subjects who completed Protocol 25543 .MedDRA version: 8.1 Level: PT Classification code 10039626 Term: SchizophreniaSchizophreniaEUCTR2005-002169-35-ITORGANON ITALIA300
进行中（未招募）
不适用
A Multicenter, Double-Blind, Flexible-Dose, 6-Month Extension Trial Comparing the safety and Efficacy of Asenapine With Olanzapine in Subjects who Completed Protocol 25543 - Aphrodite extensioSchizophrenia with predominant, persistent negative symptomsMedDRA version: 7.1Level: LLTClassification code 10039626EUCTR2005-002169-35-DEV Organon380
进行中（未招募）
1 期
A Multicenter, Double-Blind, Flexible-Dose, 6-Month Trial Comparing the Efficacy and Safety of Asenapine With Olanzapine in Stable Subjects With Predominant, Persistent Negative Symptoms of SchizophreniaSchizophrenia with predominant, persistent negative symptomsMedDRA version: 7.1 Level: LLT Classification code 10039626EUCTR2004-002560-17-FIV Organon444
进行中（未招募）
1 期
A Multicenter, Double-Blind, Flexible-Dose, 6-Month Trial Comparing the Efficacy and Safety of Asenapine With Olanzapine in Stable Subjects With Predominant, Persistent Negative Symptoms of SchizophreniaSchizophrenia with predominant, persistent negative symptomsMedDRA version: 7.1 Level: LLT Classification code 10039626EUCTR2004-002560-17-GBV Organon444
进行中（未招募）
不适用
A Multicenter, Double-Blind, Flexible-Dose, 6-Month Extension Trial Comparing the safety and Efficacy of Asenapine With Olanzapine in Subjects who Completed Protocol 25543 - Aphrodite extensioEUCTR2005-002169-35-SEV Organon380